510(k) Report

510(k) · Cleared

Cleared

ADAMS A1c HA-8180V, CALIBRATOR 80

K162822510(k) TraditionalCleared Jun 29, 2017265-day reviewClass II21 CFR 862.1373

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Arkray Factory, Inc. · PDJ Hemoglobin A1c Test System

Cleared on Jun 29, 2017 as substantially equivalent to K131580 (Tosoh Bioscience, Inc., 2014) and 1 other predicate after a 265-day review. Its family tree reaches back 3 generations to 1997.

Decided
Jun 29, 2017
Review
265 days
Class
Class II
Product code
PDJ
Recalls
None
Predicates
2

Its longest line of descent runs back 3 generations to K972265 (1997). 5 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 3 generations backK972265 A1C 2.2 Plus - Automated Glycohemoglobin AnalyzerTosoh Medics, Inc. · 1997
  2. 2 generations backK011434 G7 Automated HPLC AnalyzerTosoh Medics, Inc. · 2001 · Recalled
  3. 1 generation backK071132 G8 Automated HPLC Analyzer, Model HLC-723 G8Tosoh Bioscience, Inc. · 2008 · Recalled
  4. This deviceK162822 ADAMS A1c HA-8180V, CALIBRATOR 80Arkray Factory, Inc. · 2017
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K972265A1C 2.2 Plus - Automated Glycohemoglobin AnalyzerTosoh Medics, Inc.1997—
−2K011434G7 Automated HPLC AnalyzerTosoh Medics, Inc.20012
−1K071132G8 Automated HPLC Analyzer, Model HLC-723 G8Tosoh Bioscience, Inc.20081
0 (this device)K162822ADAMS A1c HA-8180V, CALIBRATOR 80Arkray Factory, Inc.2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
201310
201410
FIG. 1 — Lineage of K162822, 1997–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PDJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PDJ device

  1. #1 K252749 Medconn 8K Glycated Hemoglobin Test Systemscore 11.5 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K131580Automated Gylcohemoglobin Analyzer HLC-723G8
Summary page 5
…510(k) Summary ADAMS A1c HA-8180V 4. Predicate Device K131580 – Automated Glycohemoglobin Analyzer HLC-723G8 (Tosoh Bioscience, Inc.)…
Tosoh Bioscience, Inc.20142
*K071132G8 Automated HPLC Analyzer, Model HLC-723 G8
Summary page 5
…4. Predicate Device K131580 – Automated Glycohemoglobin Analyzer HLC-723G8 (Tosoh Bioscience, Inc.) K071132 – Hemoglobin A1c Calibrator Set (Tosoh Bioscience, Inc.) 5. Device Description The ADAMS A1c HA-…
Tosoh Bioscience, Inc.20081

Also cleared against K131580: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 20 years and passes through 3 companies; a new generation was cleared every 7.0 years on median.
  • 3 of the 5 ancestors have a recall of any class.
  • 2 other devices also cite its predicate K131580.

How does its category compare?

All PDJ devices

PDJ Hemoglobin A1c Test System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · PDJ

2in 2025

2013: 22014: 22015: 42016: 22017: 32018: 52019: 12020: 12021: 22024: 12025: 22026 (partial year): 2
2007high 5 (2018) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PDJ

203in 2018

2015: 234 days median2017: 173 days median2018: 203 days median
2007high 234 (2015) · low 173 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · PDJ

1in 2022

2016: 12022: 12026 (partial year): 1
2007high 1 (2016) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · PDJ

42in 2025

2013: 92014: 102015: 22017: 12020: 52021: 62022: 192023: 162024: 472025: 42
2007high 47 (2024) · low 0 (2007)2025

MAUDE reports naming product code PDJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20132—09
20142—010
2015423402
20162—10
2017317301
2018520300
20191—00
20201—05
20212—06
20220—119
20230—016
20241—047
20252—042
20262—1—

What is it indicated for?

The ADAMS A1c HA-8180V system is intended for the quantitative determination of hemoglobin A1c (IFCC mmol/mol and NGSP %) in human whole blood and hemolysate samples using Ion Exchange high performance liquid chromatography (HPLC). Hemoglobin A1c measurements obtained from the ADAMS A1C HA-8180V are used as an aid in the diagnosis of diabetes mellitus, an aid in the identification of individuals who may be at risk of developing diabetes, and for the…

Read the full statement (127 words)

The ADAMS A1c HA-8180V system is intended for the quantitative determination of hemoglobin A1c (IFCC mmol/mol and NGSP %) in human whole blood and hemolysate samples using Ion Exchange high performance liquid chromatography (HPLC).

Hemoglobin A1c measurements obtained from the ADAMS A1C HA-8180V are used as an aid in the diagnosis of diabetes mellitus, an aid in the identification of individuals who may be at risk of developing diabetes, and for the monitoring of long-term blood glucose control in individuals with diabetes mellitus. The ADAMS A1c HA-8180V is intended for Professional Use Only.

The CALIBRATOR 80 is for the calibration of the ADAMS A1c HA-8180V system used for the quantitative determination of hemoglobin A1c in human whole blood and hemolysate samples.

For In Vitro Diagnostic Use Only.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K162822: ADAMS A1c HA-8180V, CALIBRATOR 80.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K162822

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026